|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
53,543,000 |
Market
Cap: |
11.06(B) |
Last
Volume: |
666,758 |
Avg
Vol: |
474,971 |
52
Week Range: |
$164.52 - $273.43 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 400 MIDCAP |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 456 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Charles River Laboratories International is a contract research organization. Co. has a laboratory animal medicine and science to develop a portfolio of discovery and safety assessment services. Co.'s segments include: Research Models and Services, which supplies research models to the drug development industry; Discovery and Safety Assessment (DSA), which provides DSA services, including in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development; Manufacturing Support, which ensure the safe production and release of products manufactured by Co.'s clients.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
7,942 |
11,192 |
Total Buy Value |
$0 |
$0 |
$1,447,725 |
$2,162,353 |
Total People Bought |
0 |
0 |
3 |
3 |
Total Buy Transactions |
0 |
0 |
3 |
5 |
Total Shares Sold |
1,636 |
25,558 |
49,996 |
92,833 |
Total Sell Value |
$374,194 |
$6,377,856 |
$11,292,577 |
$21,658,880 |
Total People Sold |
2 |
6 |
6 |
8 |
Total Sell Transactions |
2 |
10 |
16 |
28 |
End Date |
2024-03-31 |
2023-12-29 |
2023-06-30 |
2022-06-30 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Massaro George |
Director |
|
2018-05-14 |
4 |
AS |
$106.05 |
$130,558 |
D/D |
(1,218) |
13,837 |
|
- |
|
Massaro George |
Director |
|
2018-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
2,004 |
15,055 |
|
- |
|
Reese C Richard |
Director |
|
2018-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
2,703 |
59,160 |
|
- |
|
Thompson Craig B. |
Director |
|
2018-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
2,657 |
17,586 |
|
- |
|
Wallman Richard F |
Director |
|
2018-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
2,680 |
26,928 |
|
- |
|
Chubb Stephen D |
Director |
|
2018-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
2,004 |
35,593 |
|
- |
|
Bertolini Robert J |
Director |
|
2018-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
2,750 |
25,336 |
|
- |
|
Smith David Ross |
Corporate Executive VP & CFO |
|
2018-05-01 |
4 |
AS |
$103.67 |
$98,499 |
D/D |
(945) |
12,778 |
|
- |
|
Smith David Ross |
Corporate Executive VP & CFO |
|
2018-05-01 |
4 |
OE |
$51.45 |
$48,620 |
D/D |
945 |
13,723 |
|
- |
|
Smith David Ross |
Corporate Executive VP & CFO |
|
2018-05-01 |
4 |
D |
$104.19 |
$33,862 |
D/D |
(325) |
12,778 |
|
- |
|
Knell Michael Gunnar |
CSVP&Chief Accounting Officer |
|
2018-05-01 |
4 |
D |
$104.19 |
$6,356 |
D/D |
(61) |
1,527 |
|
- |
|
Milne George M Jr |
Director |
|
2018-03-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,280 |
26,740 |
|
- |
|
Milne George M Jr |
Director |
|
2018-03-09 |
4 |
AS |
$115.00 |
$890,100 |
D/D |
(7,740) |
29,020 |
|
- |
|
Milne George M Jr |
Director |
|
2018-03-09 |
4 |
OE |
$40.27 |
$311,690 |
D/D |
7,740 |
36,760 |
|
- |
|
Girshick Birgit |
Corporate Executive VP |
|
2018-03-06 |
4 |
S |
$109.00 |
$1,079,343 |
D/D |
(9,893) |
22,977 |
|
- |
|
Girshick Birgit |
Corporate Executive VP |
|
2018-03-06 |
4 |
OE |
$59.41 |
$579,694 |
D/D |
7,313 |
32,870 |
|
- |
|
Foster James C |
Chairman & CEO |
|
2018-03-06 |
4 |
AS |
$110.00 |
$2,640,880 |
D/D |
(24,008) |
301,676 |
|
- |
|
Foster James C |
Chairman & CEO |
|
2018-03-06 |
4 |
OE |
$88.05 |
$2,113,904 |
D/D |
24,008 |
325,684 |
|
- |
|
Barbo William D |
Corporate Executive VP & CCO |
|
2018-02-28 |
4 |
D |
$107.82 |
$21,780 |
D/D |
(202) |
20,980 |
|
- |
|
Girshick Birgit |
Corporate Executive VP |
|
2018-02-28 |
4 |
D |
$107.82 |
$7,224 |
D/D |
(67) |
25,557 |
|
- |
|
Johst David P |
Corporate Executive VP |
|
2018-02-28 |
4 |
D |
$107.82 |
$69,652 |
D/D |
(646) |
196,493 |
|
- |
|
Smith David Ross |
Corporate Executive VP & CFO |
|
2018-02-28 |
4 |
S |
$108.43 |
$10,843 |
D/D |
(100) |
13,103 |
|
- |
|
Smith David Ross |
Corporate Executive VP & CFO |
|
2018-02-28 |
4 |
S |
$107.29 |
$565,414 |
D/D |
(5,240) |
13,203 |
|
- |
|
Smith David Ross |
Corporate Executive VP & CFO |
|
2018-02-28 |
4 |
OE |
$88.05 |
$384,338 |
D/D |
4,365 |
18,443 |
|
- |
|
Molho Davide |
President & COO |
|
2018-02-28 |
4 |
D |
$107.82 |
$65,231 |
D/D |
(605) |
20,669 |
|
- |
|
1200 Records found
|
|
Page 29 of 48 |
|
|